ALBIO logo

Biosynex SA Stock Price

ENXTPA:ALBIO Community·€9.8m Market Cap
  • 0 Narratives written by author
  • 0 Comments on narratives written by author
  • 0 Fair Values set on narratives written by author

ALBIO Share Price Performance

€0.52
-2.32 (-81.65%)
€0.52
-2.32 (-81.65%)
Price €0.52

ALBIO Community Narratives

There are no narratives available yet.

Snowflake Analysis

Moderate risk and slightly overvalued.

5 Risks
0 Rewards

Biosynex SA Key Details

€98.0m

Revenue

€40.4m

Cost of Revenue

€57.5m

Gross Profit

€128.5m

Other Expenses

-€71.0m

Earnings

Last Reported Earnings
Jun 30, 2025
Next Reporting Earnings
n/a
-3.79
58.71%
-72.47%
126.9%
View Full Analysis

About ALBIO

Founded
1993
Employees
454
CEO
Larry Abensur
WebsiteView website
www.biosynex.com

Biosynex SA designs, manufactures, and distributes rapid diagnostic tests in France and internationally. The company offers medical devices for in vitro diagnosis in the form of rapid diagnostic tests, immunoblots, molecular biology, and point of care products for screening, diagnosis, and prevention in the areas of bacteriology, parasitology, mycology, virology, biochemistry and oncology, and women’s health, as well as COVID-19 tests and instruments. It also provides self-tests; self-measurement products, including thermometers, oxymeters, and blood pressure monitors; and oral care and medical aid products. The company provides its products to biology and medical analysis laboratories, hospitals, pharmacies, hyper and supermarkets, etc. It also exports its products internationally. The company was founded in 1993 and is based in Illkirch-Graffenstaden, France.